Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Symrise AG    SY1   DE000SYM9999

SYMRISE AG

(SY1)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Symrise : statement on the corona situation

share with twitter share with LinkedIn share with facebook
share via e-mail
03/23/2020 | 04:41am EDT

Dear Partners and Friends of Symrise,

The corona pandemic presents us with a challenging environment worldwide. Symrise is closely monitoring the development of the COVID 19 situation and its impact on various aspects of its business.

At the moment, all of Symrise's production sites are continuing to operate, even in the so called hot spots. We experience some delays in the delivery of raw materials. This is due to limited international logistics.

Within our risk mitigation approach, the crisis team is exploring, defining and implementing appropriate measures to ensure the continuous operation of our sites. These measures follow the Symrise protocols for pandemic crisis situations and are tailored to the country-specific requirements of the national authorities.

The safety of our employees and business partners is particularly important to us. We have therefore created solutions for working from home and introduced staggered shift models in production and in the laboratories to keep contact between our employees as low as possible. Thanks to these measures, Symrise has so far prevented any effects on the health situation of its employees.

Extended preventive measures at the Symrise sites:

Restriction of business trips and visitors on site

Intensified hygiene regulations (precise instructions for washing hands, no shaking hands, etc.)

Improved cleaning and disinfection routines

Implementation of guidelines for working from home and separation of shifts as well as teams to reduce contact

Exchange and cooperation with local authorities on the situation

The health of our employees and business partners is a top priority for our company. We are confident that we will overcome this crisis together.

Yours sincerely,

Symrise Executive Board

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SYMRISE AG
05/27SYMRISE : opens production site in China
PU
05/27SYMRISE AG : UBS reiterates its Neutral rating
MD
05/27SYMRISE : Three Symrise products win first prize at the BSB Innovation Awards 20..
AQ
05/22SYMRISE AG : NorldLB sticks Neutral
MD
05/20SYMRISE : honors Coronavirus essential workers with HERO cologne
AQ
05/18SYMRISE AG : Gets a Neutral rating from UBS
MD
05/15SYMRISE AG : Gets a Sell rating from JP Morgan
MD
05/14SYMRISE AG : Gets a Buy rating from Goldman Sachs
MD
05/14PROBI PUBL : A true pioneer in probiotic research is elected NutraChampion 2020
AQ
05/13PROBI PUBL : Annual General Meeting 2020
AQ
More news
Financials
Sales 2020 3 680 M 4 087 M 4 087 M
Net income 2020 343 M 381 M 381 M
Net Debt 2020 1 442 M 1 602 M 1 602 M
P/E ratio 2020 39,4x
Yield 2020 1,07%
Capitalization 13 326 M 14 815 M 14 801 M
EV / Sales 2019
EV / Sales 2020 4,01x
Nbr of Employees 10 264
Free-Float 91,2%
Chart SYMRISE AG
Duration : Period :
Symrise AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYMRISE AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 25
Average target price 91,63 €
Last Close Price 98,40 €
Spread / Highest target 27,0%
Spread / Average Target -6,88%
Spread / Lowest Target -47,2%
EPS Revisions
Managers
NameTitle
Heinz-Jürgen Bertram Chief Executive Officer
Winfried Steeger Chairman-Supervisory Board
Olaf Klinger Chief Financial Officer
Horst-Otto Gerberding Member-Supervisory Board
Peter Winkelmann Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SYMRISE AG4.90%14 815
ECOLAB INC.10.15%61 479
GIVAUDAN13.72%33 050
SIKA AG-9.54%24 252
EMS-CHEMIE HOLDING AG11.63%17 285
HITACHI CHEMICAL COMPANY, LTD.0.87%8 922